All News
Delays in Diagnosing Generalized Myasthenia Gravis
(MedPage Today) -- Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement i
Read MoreAn awkward moment for Pfizer’s Bourla in Washington
The Pfizer CEO at the White House, CDC vaccine efforts, and other crucial biotech news.
Read MoreSTAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.
Read MoreSTAT+: Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders
The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.
Read MoreCDC Kills Vaccine Campaign; Bird Flu Now in Rats; Pope Francis Improving
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Pharmalittle: We’re reading about RFK Jr. targeting CDC and FDA advisers, a Pfizer gene therapy program, and more
HHS Secretary Robert F. Kennedy Jr.
Read MoreCould housecats act as a vector to spread the H5N1 virus?
Plus more health news stories you need to read this morning.
Read MoreReport: RFK Jr. Planning to Remove Advisors on Vaccine Committee
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr. appears to be planning major changes to the way his department oversees vaccines, media outlets are reporting.
Read MoreSTAT+: Bluebird Bio sells itself to Carlyle, SK Capital for less than $30 million
Bluebird Bio announced it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $30 million.
Read MoreDoctors in London cure blindness in children with rare condition – video report
Doctors in London have become the first in the world to cure blindness in children born with a rare genetic condition using gene therapy.
Read More